Marsh James C, Goldman Stewart, Ziel Ellis, Bregman Corey, Diaz Aidnag, Byrne Richard, Fangusaro Jason
21st Century Oncology of Arizona, Peoria, AZ, USA,
J Neurooncol. 2015 Mar;122(1):105-10. doi: 10.1007/s11060-014-1682-0. Epub 2014 Dec 11.
To assess frequency of neural stem cell compartment (NSC) involvement in adult and pediatric gliomas [World Health Organization (WHO) grades 1-4], and to assess whether NSC involvement at presentation impacts on survival, recurrence rates, and/or transformation from low grade (WHO grade 1-2) to high grade disease (WHO grades 3-4). Cranial MRIs for 154 pediatric and 223 adult glioma patients treated from 2000 to 2012 were reviewed. NSC involvement was documented. Tumors were stratified by age (adult vs. pediatric), histology, tumor grade, tumor location, and involvement of midline structures. Odds ratios (OR) for death were calculated based on NSC status at presentation. Rates of transformation and recurrence rates (ORR) were compared using Fisher's Exact Test. Time to recurrence (TTR) was calculated using student t test. Among recurrent and transformed tumors, we also assessed the rate of NSC involvement at time of recurrence or transformation. 74.8 % of tumors had NSC involvement. Higher rates of NSC involvement were seen among adult (p = .0001); high grade (p = .0001)); grade 2 versus grade 1 (p = .0001) and other grade 1 histologies (p = .0001) versus JPA (juvenile pilocytic astrocytoma) patients); grade 2-4 tumors (p = .0001); and supratentorial tumors (p < .0001). No transformation was noted among pediatric low grade tumors or adult grade 1 tumors. 22/119 (18.5 %) adult grade 2 tumors transformed. Rates of transformation were not impacted by NSC status (p = .47). ORR was 15.1 %, and was greater for NSC+ tumors at presentation (p = .05). 36/41 recurrences (87.8 %) involved NSC at time of recurrence. OR for death was 2.62 (1.16-5.9), p = .02 for NSC+ tumors at presentation. Adult and pediatric gliomas (all grades) frequently involve NSC at presentation, although rates are lower in pediatric JPA and all infratentorial tumors. NSC involvement at presentation increases OR death and reduces TTR for pediatric gliomas (all grades) and adult low grade gliomas, and shows a strong trend toward increased ORR.
评估神经干细胞区室(NSC)在成人和儿童胶质瘤(世界卫生组织(WHO)1 - 4级)中的受累频率,并评估发病时NSC受累是否会影响生存率、复发率和/或从低级别(WHO 1 - 2级)向高级别疾病(WHO 3 - 4级)的转变。回顾了2000年至2012年接受治疗的154例儿童和223例成人胶质瘤患者的头颅磁共振成像(MRI)。记录NSC受累情况。肿瘤按年龄(成人与儿童)、组织学、肿瘤分级、肿瘤位置和中线结构受累情况进行分层。根据发病时的NSC状态计算死亡比值比(OR)。使用Fisher精确检验比较转变率和复发率(ORR)。使用学生t检验计算复发时间(TTR)。在复发和转变的肿瘤中,我们还评估了复发或转变时NSC受累的发生率。74.8%的肿瘤有NSC受累。成人(p = 0.0001)、高级别(p = 0.0001)、2级与1级(p = 0.0001)以及其他1级组织学类型与少年毛细胞型星形细胞瘤(JPA)患者(p = 0.0001)、2 - 4级肿瘤(p = 0.0001)和幕上肿瘤(p < 0.0001)中NSC受累率较高。儿童低级别肿瘤或成人1级肿瘤未观察到转变。22/119(18.5%)例成人2级肿瘤发生转变。转变率不受NSC状态影响(p = 0.47)。ORR为15.1%,发病时NSC阳性肿瘤的ORR更高(p = 0.05)。36/41例复发(87.8%)在复发时累及NSC。发病时NSC阳性肿瘤的死亡OR为2.62(1.16 - 5.9),p = 0.02。成人和儿童胶质瘤(所有级别)发病时经常累及NSC,尽管儿童JPA和所有幕下肿瘤的发生率较低。发病时NSC受累会增加儿童胶质瘤(所有级别)和成人低级别胶质瘤的死亡OR并缩短TTR,且显示出ORR增加的强烈趋势。